Biden Admin Using DPA To Bring 60M At-Home COVID-19 Tests To Market

By Kelly Lienhard / February 5, 2021 at 2:52 PM
The federal government has directed six different manufactures to ramp up domestic production of non-prescription, at-home COVID-19 tests under the Defense Production Act, the White House’s COVID-19 Response Team revealed Friday (Feb. 5). Under the agreements, the administration will help industry partners build new U.S.-based plants and production to surge capacity and help Americans safely return to normal life. The agreements announced Friday are in addition to HHS’ $230 million contract with Ellume to provide 8.5 million at-home tests to...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.